PDGFRA and neoplasm: However, our findings confirmed the low maximum VAF of ctDNA without KIT or PDGFRA mutations, leading us to hypothesize that clonal evolution related to acquired resistance mechanisms may shed light on this phenomenon, potentially indicating treatment response and the low tumor fraction harboring original alterations.